As of 2025-05-13, the Relative Valuation of Mersana Therapeutics Inc (MRSN) is (15.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.36 USD, the upside of Mersana Therapeutics Inc based on Relative Valuation is -4280.0%.
The range of the Relative Valuation is (12.99) - (17.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 32.6x | 24.9x |
| Forward P/E multiples | 23.4x - 31.5x | 29.4x |
| Fair Price | (12.99) - (17.50) | (15.07) |
| Upside | -3702.7% - -4952.8% | -4280.0% |
| Date | P/E |
| 2025-05-12 | -0.65 |
| 2025-05-09 | -0.57 |
| 2025-05-08 | -0.60 |
| 2025-05-07 | -0.58 |
| 2025-05-06 | -0.57 |
| 2025-05-05 | -0.66 |
| 2025-05-02 | -0.72 |
| 2025-05-01 | -0.72 |
| 2025-04-30 | -0.78 |
| 2025-04-29 | -0.67 |
| 2025-04-28 | -0.69 |
| 2025-04-25 | -0.66 |
| 2025-04-24 | -0.65 |
| 2025-04-23 | -0.70 |
| 2025-04-22 | -0.68 |
| 2025-04-21 | -0.59 |
| 2025-04-17 | -0.64 |
| 2025-04-16 | -0.60 |
| 2025-04-15 | -0.63 |
| 2025-04-14 | -0.60 |
| 2025-04-11 | -0.56 |
| 2025-04-10 | -0.47 |
| 2025-04-09 | -0.55 |
| 2025-04-08 | -0.53 |
| 2025-04-07 | -0.55 |
| 2025-04-04 | -0.55 |
| 2025-04-03 | -0.55 |
| 2025-04-02 | -0.61 |
| 2025-04-01 | -0.60 |
| 2025-03-31 | -0.62 |
| 2025-03-28 | -0.68 |
| 2025-03-27 | -0.67 |
| 2025-03-26 | -0.74 |
| 2025-03-25 | -0.81 |
| 2025-03-24 | -0.80 |
| 2025-03-21 | -0.77 |
| 2025-03-20 | -0.80 |
| 2025-03-19 | -0.83 |
| 2025-03-18 | -0.84 |
| 2025-03-17 | -0.86 |
| 2025-03-14 | -0.84 |
| 2025-03-13 | -0.81 |
| 2025-03-12 | -0.92 |
| 2025-03-11 | -0.87 |
| 2025-03-10 | -0.90 |
| 2025-03-07 | -0.98 |
| 2025-03-06 | -0.95 |
| 2025-03-05 | -0.92 |
| 2025-03-04 | -0.92 |
| 2025-03-03 | -0.86 |